Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Hepatic Drug Excretion: Enterohepatic Cycling

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Peer review of the pesticide risk assessment of the active substance cymoxanil.

EFSA journal. European Food Safety Authority·2026

Same author

Peer review of the pesticide risk assessment for the active substance bifenazate in light of confirmatory data submitted.

EFSA journal. European Food Safety Authority·2026

Same author

<b>The parasitic bopyrid isopods of porcellanid crabs (Anomura: Porcellanidae) of the Colección Nacional de Crustáceos of Mexico: with the description of <i>Aporobopyrus adriani</i> sp. nov. and <i>Orbimorphus boykoi</i> sp. nov. (Epicaridea: Bopyridae)</b>.

Zootaxa·2026

Same author

Peer review of the pesticide risk assessment of the active substance proquinazid.

EFSA journal. European Food Safety Authority·2026

Same author

Optimal timing of infant post-vaccination serological testing for hepatitis B virus immunity.

Canadian liver journal·2026

Same author

Peer review of the pesticide risk assessment of the active substance metyltetraprole.

EFSA journal. European Food Safety Authority·2026

Search research articles

Related Experiment Video

Updated: Nov 4, 2025

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C: Could we eradicate this virus?

Fernando Álvarez¹, Miriam L Cuarterolo², Mirta Ciocca³

¹Departamento de Pediatría, CHUSainte Justine, Universidad de Montreal, Canadá. fernando.alvarez@umontreal.ca.

Archivos Argentinos De Pediatria

|May 25, 2021

Summary

This summary is machine-generated.

Chronic hepatitis C virus (HCV) infection affects children and adults globally. New direct-acting antivirals offer a cure for most patients, highlighting the need for pediatrician awareness and specialist referral.

Keywords:

cirrhosis direct-acting antivirals hepatitis C therapy

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Experiment Videos

Last Updated: Nov 4, 2025

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Area of Science:

Hepatology
Virology
Pediatrics

Background:

Chronic hepatitis C virus (HCV) infection is a global health concern affecting both children and adults.
While spontaneous resolution is possible in early childhood, it becomes uncommon later.
Untreated childhood HCV can lead to adult cirrhosis and hepatocellular carcinoma.

Purpose of the Study:

To emphasize the importance of early detection and management of chronic hepatitis C in children.
To highlight the efficacy of direct-acting antivirals (DAAs) in treating HCV.
To advocate for increased pediatrician awareness and referral to pediatric liver specialists.

Main Methods:

Review of current literature on chronic hepatitis C in pediatric populations.
Analysis of the impact of direct-acting antiviral therapies on HCV eradication rates.
Discussion of the clinical progression of HCV from childhood to adulthood.

Main Results:

Direct-acting antivirals achieve high rates of HCV infection resolution (97-100%).
Early childhood infection may resolve spontaneously, but adult complications are significant.
Effective management requires early diagnosis and specialist intervention.

Conclusions:

Hepatitis C virus infection in children requires prompt diagnosis and management.
Direct-acting antivirals represent a highly effective cure for chronic HCV.
Enhanced pediatrician awareness is crucial for timely referral and improved patient outcomes.